Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella urinary antigen EIA

Citation
Jh. Helbig et al., Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella urinary antigen EIA, J MED MICRO, 50(6), 2001, pp. 509-516
Citations number
27
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF MEDICAL MICROBIOLOGY
ISSN journal
00222615 → ACNP
Volume
50
Issue
6
Year of publication
2001
Pages
509 - 516
Database
ISI
SICI code
0022-2615(200106)50:6<509:DOLPAI>2.0.ZU;2-U
Abstract
The new BinaxNOW Immunochromatographic (ICT) Assay for the detection of Leg ionella pneumophila antigens was used to test 535 urine specimens from pati ents with and without Legionnaires' disease. The specificity, calculated by testing 112 samples from patients with pneumonia of aetiologies other than Legionella infection, and 167 urine specimens from urinary tract infection s, was found to be 97.1% if the manufacturer's guidelines were followed. Ho wever, it was determined that the 'false positive' results characterised by very weak bands could be discounted by reexamination of the results at 60 min, yielding a specificity of 100%, With this minor modification of the pr ocedure applied to examination of urine samples from 117 patients with legi onellosis confirmed by isolation of L, pneumophila and 70 patients who had seroconverted to L, pneumophila serogroup 1, sensitivity was calculated to be 79.7%. In comparison, the sensitivities of the Binax Urinary Antigen Enz yme Immunoassay (EIA) and Biotest Urin Antigen EIA were estimated to be 79. 1 and 83.4%, respectively. Eleven cases (5.9%) were positive by BinaxNOW as say but negative by Binax or Biotest EIA, or both. The sensitivities of all assays increased to c. 94% if only diagnosis of cases confirmed by isolati on of serogroup 1 L, pneumophila was considered, although the sensitivity f or infections caused by L. pneumophila serogroup 1 monoclonal antibody (MAb ) subgroup Bellingham was significantly lower than for other MAb subgroups. The Biotest EIA recognised 10 (45%) of the 22 cases not caused by L, pneum ophila serogroup 1, whereas the two Binax kits detected only three each. Th e ICT assay BinaxNOW can be recommended as a rapid specific test for the di agnosis of Legionnaires' diseases caused by L, pneumophila serogroup 1, alt hough very weak bands should be interpreted cautiously.